P2.06-021 Efficacy and Safety of ASP8273 versus Erlotinib or Gefitinib as First-Line Treatment in Subjects with EGFRMut+ NSCLC: Topic: Phase III
| Autor: | Kelly, Ronan, Horn, Leora, Chih-Hsin Yang, James, Lee, Dae Ho, Desai, Bhardwaj, Fleege, Tanya, Jie, Fei, Poondru, Srinivasu, Keating, Anne, Whitcomb, Debbie, Murase, Tosei, Uegaki, Koichi, Aoyama, Kouji, Nakagawa, Kazuhiko |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology January 2017 12(1) Supplement:S1083-S1084 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|